Concepedia

A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers

Jing Wei, Huiyan Sun, Aimei Zhang, Xuejie Wu, Lisheng Wang, Chu-Tse Wu

Cellular Immunology · 2018 · 108 citations · 35 references

DOI

Concepts

References

35

Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

K. T. Brunner, Jacques Mauël, J C Cerottini et al. · PubMed · 1968 · 1.4K citations · Full text

, , +10

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

Thomas Decker, Marie‐Luise Lohmann‐Matthes · Journal of Immunological Methods · 1988 · 1.4K citations

, , +6

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

F. Michael Yakes, Jason Chen, Jenny Tan et al. · Molecular Cancer Therapeutics · 2011 · 1.3K citations · Full text

, , +17

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin et al. · Nature Genetics · 2012 · 1.2K citations

, , +16

Identification of the Product of Growth Arrest-specific Gene 6 as a Common Ligand for Axl, Sky, and Mer Receptor Tyrosine Kinases

Kyoko Nagata, Kazumasa Ohashi, Toru Nakano et al. · Journal of Biological Chemistry · 1996 · 527 citations · Full text

, , +17